Skip to main content
Erschienen in: Clinical Research in Cardiology 11/2011

01.11.2011 | Original Paper

Repair for active infective atrioventricular valve endocarditis: 23-year single center experience

verfasst von: Michele Musci, Michael Hübler, Aref Amiri, Julia Stein, Susanne Kosky, Yuguo Weng, Miralem Pasic, Roland Hetzer

Erschienen in: Clinical Research in Cardiology | Ausgabe 11/2011

Einloggen, um Zugang zu erhalten

Abstract

Objectives

We retrospectively compared early and long-term results of mitral (MV) and tricuspid valve (TV) repair in patients with isolated active infective atrioventricular valve (AV) endocarditis over a period of 23 years.

Methods

Between April 1986 and December 2009, a total of 1,409 patients with active infective endocarditis (AIE) were operated upon. Of these, 106 (7.2%) patients (n = 69 men, age 2–84 years) underwent repair of AVE (MV n = 68, TV n = 38). Repair techniques included vegetectomy and leaflet resection, annular plication and annuloplasty, and pericardial patch leaflet and annular reconstruction without any artificial device. Perioperative characteristics, probability of survival, freedom from recurrence and reoperation, and predictors for early mortality were analyzed. Follow-up (0–23 years) was completed in 95% with a total of 667 patient years.

Results

The 30-day, 1-, 5- and 10-year survival rate for MV repair was 89.7 ± 0.4, 82.2 ± 4.6, 72.6 ± 5.5 and 56.5 ± 7.3% and for TV repair 94.7 ± 3.7, 88.7 ± 5.3, 69.4 ± 8.8 and 64.5 ± 9.5%, respectively (ns).
Three patients (2.8%) had to undergo reoperation due to early failure of reconstruction (n = 2 MV, n = 1 TV). Freedom from valve-related reoperation at 1 and 10 years was 88.4 ± 4.1 and 75.4 ± 7.4% for the MV repair and 97.4 ± 2.6 and 93.94 ± 4.2% for the TV repair group (ns).
Endocarditis reoccurred early in 2  MV repair patients (1.9%). Freedom from reoperation due to reinfection at 1 and 10 years after MV repair was 96.6 ± 2.3 and 91.6 ± 5.4% and after TV repair 100 and 83.3 ± 9.5%.

Conclusions

Repair for AV endocarditis yields excellent results. It is associated with low operative mortality and provides satisfactory early and long-term survival and favorable freedom from recurrent endocarditis and repeat operation. It should be considered as the primary surgical option in these patients, and AV replacement should be performed only in cases of severe AV destruction that renders repair techniques impossible.
Literatur
1.
Zurück zum Zitat Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Page RL, Riegel B (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114:e84–e231PubMedCrossRef Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Page RL, Riegel B (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114:e84–e231PubMedCrossRef
2.
Zurück zum Zitat Sarralde JA, Bernal JM, Llorca J, Ponton A, Diez-Solorzano L, Gimenez-Rico JR, Revuelta JM (2010) Repair of rheumatic tricuspid valve disease: predictors of very long-term mortality and reoperation. Ann Thorac Surg 90:503–508PubMedCrossRef Sarralde JA, Bernal JM, Llorca J, Ponton A, Diez-Solorzano L, Gimenez-Rico JR, Revuelta JM (2010) Repair of rheumatic tricuspid valve disease: predictors of very long-term mortality and reoperation. Ann Thorac Surg 90:503–508PubMedCrossRef
3.
Zurück zum Zitat Bernal JM, Ponton A, Diaz B, Llorca J, Garcia I, Sarralde JA, Gutierrez-Morlote J, Perez-Negueruela C, Revuelta JM (2010) Combined mitral and tricuspid valve repair in rheumatic valve disease: fewer reoperations with prosthetic ring annuloplasty. Circulation 121:1934–1940PubMedCrossRef Bernal JM, Ponton A, Diaz B, Llorca J, Garcia I, Sarralde JA, Gutierrez-Morlote J, Perez-Negueruela C, Revuelta JM (2010) Combined mitral and tricuspid valve repair in rheumatic valve disease: fewer reoperations with prosthetic ring annuloplasty. Circulation 121:1934–1940PubMedCrossRef
4.
Zurück zum Zitat Moss RR, Humphries KH, Gao M, Thompson CR, Abel JG, Fradet G, Munt BI (2003) Outcome of mitral valve repair or replacement: a comparison by propensity score analysis. Circulation 108:II90–II97PubMedCrossRef Moss RR, Humphries KH, Gao M, Thompson CR, Abel JG, Fradet G, Munt BI (2003) Outcome of mitral valve repair or replacement: a comparison by propensity score analysis. Circulation 108:II90–II97PubMedCrossRef
5.
Zurück zum Zitat Maier LS, Schirmer SH, Walenta K, Jacobshagen C, Bohm M (2009) Hotline update of clinical trials and registries presented at the German Cardiac Society Meeting 2009. Clin Res Cardiol 98:413–419PubMedCrossRef Maier LS, Schirmer SH, Walenta K, Jacobshagen C, Bohm M (2009) Hotline update of clinical trials and registries presented at the German Cardiac Society Meeting 2009. Clin Res Cardiol 98:413–419PubMedCrossRef
6.
Zurück zum Zitat Robicsek F, Payne RB, Daugherty HK, Sanger PW (1967) Bacterial endocarditis of the mitral valve treated by excision and replacement. Ann Surg 166:854–857PubMedCrossRef Robicsek F, Payne RB, Daugherty HK, Sanger PW (1967) Bacterial endocarditis of the mitral valve treated by excision and replacement. Ann Surg 166:854–857PubMedCrossRef
7.
Zurück zum Zitat Dreyfus G, Serraf A, Jebara VA, Deloche A, Chauvaud S, Couetil JP, Carpentier A (1990) Valve repair in acute endocarditis. Ann Thorac Surg 49:706–713PubMedCrossRef Dreyfus G, Serraf A, Jebara VA, Deloche A, Chauvaud S, Couetil JP, Carpentier A (1990) Valve repair in acute endocarditis. Ann Thorac Surg 49:706–713PubMedCrossRef
8.
Zurück zum Zitat Chandraratna PA, Reagan RB, Imaizumi T, Langevin E, Elkins RC (1978) Infective endocarditis cured by resection of a tricuspid valve vegetation. Ann Intern Med 89:517–518PubMed Chandraratna PA, Reagan RB, Imaizumi T, Langevin E, Elkins RC (1978) Infective endocarditis cured by resection of a tricuspid valve vegetation. Ann Intern Med 89:517–518PubMed
9.
Zurück zum Zitat Khonsari S, Starr A (1983) Acquired disease of the tricuspid valve. In: Sabiston DC, Spencer (eds) Gibbon’s surgery of the chest. Saunders, Canada, pp 1211–1224 Khonsari S, Starr A (1983) Acquired disease of the tricuspid valve. In: Sabiston DC, Spencer (eds) Gibbon’s surgery of the chest. Saunders, Canada, pp 1211–1224
10.
Zurück zum Zitat Gottardi R, Bialy J, Devyatko E, Tschernich H, Czerny M, Wolner E, Seitelberger R (2007) Midterm follow-up of tricuspid valve reconstruction due to active infective endocarditis. Ann Thorac Surg 84:1943–1948PubMedCrossRef Gottardi R, Bialy J, Devyatko E, Tschernich H, Czerny M, Wolner E, Seitelberger R (2007) Midterm follow-up of tricuspid valve reconstruction due to active infective endocarditis. Ann Thorac Surg 84:1943–1948PubMedCrossRef
11.
Zurück zum Zitat Feringa HH, Shaw LJ, Poldermans D, Hoeks S, van der Wall EE, Dion RA, Bax JJ (2007) Mitral valve repair and replacement in endocarditis: a systematic review of literature. Ann Thorac Surg 83:564–570PubMedCrossRef Feringa HH, Shaw LJ, Poldermans D, Hoeks S, van der Wall EE, Dion RA, Bax JJ (2007) Mitral valve repair and replacement in endocarditis: a systematic review of literature. Ann Thorac Surg 83:564–570PubMedCrossRef
12.
Zurück zum Zitat Lange R, De Simone R, Bauernschmitt R, Tanzeem A, Schmidt C, Hagl S (1996) Tricuspid valve reconstruction, a treatment option in acute endocarditis. Eur J Cardiothorac Surg 10:320–326PubMedCrossRef Lange R, De Simone R, Bauernschmitt R, Tanzeem A, Schmidt C, Hagl S (1996) Tricuspid valve reconstruction, a treatment option in acute endocarditis. Eur J Cardiothorac Surg 10:320–326PubMedCrossRef
13.
Zurück zum Zitat Bernal JM, Ponton A, Diaz B, Llorca J, Garcia I, Sarralde A, Diago C, Revuelta JM (2008) Surgery for rheumatic tricuspid valve disease: a 30-year experience. J Thorac Cardiovasc Surg 136:476–481PubMedCrossRef Bernal JM, Ponton A, Diaz B, Llorca J, Garcia I, Sarralde A, Diago C, Revuelta JM (2008) Surgery for rheumatic tricuspid valve disease: a 30-year experience. J Thorac Cardiovasc Surg 136:476–481PubMedCrossRef
14.
Zurück zum Zitat Musci M, Weng Y, Hubler M, Amiri A, Pasic M, Kosky S, Stein J, Siniawski H, Hetzer R (2010) Homograft aortic root replacement in native or prosthetic active infective endocarditis: 20-year single-center experience. J Thorac Cardiovasc Surg 139:665–673 Musci M, Weng Y, Hubler M, Amiri A, Pasic M, Kosky S, Stein J, Siniawski H, Hetzer R (2010) Homograft aortic root replacement in native or prosthetic active infective endocarditis: 20-year single-center experience. J Thorac Cardiovasc Surg 139:665–673
15.
Zurück zum Zitat Musci M, Siniawski H, Pasic M, Weng Y, Loforte A, Kosky S, Yankah C, Hetzer R (2008) Surgical therapy in patients with active infective endocarditis: 7-year single centre experience in a subgroup of 255 patients treated with the Shelhigh stentless bioprosthesis. Eur J Cardiothorac Surg 34:410–417PubMedCrossRef Musci M, Siniawski H, Pasic M, Weng Y, Loforte A, Kosky S, Yankah C, Hetzer R (2008) Surgical therapy in patients with active infective endocarditis: 7-year single centre experience in a subgroup of 255 patients treated with the Shelhigh stentless bioprosthesis. Eur J Cardiothorac Surg 34:410–417PubMedCrossRef
16.
Zurück zum Zitat de Kerchove L, Vanoverschelde JL, Poncelet A, Glineur D, Rubay J, Zech F, Noirhomme P, El Khoury G (2007) Reconstructive surgery in active mitral valve endocarditis: feasibility, safety and durability. Eur J Cardiothorac Surg 31:592–599PubMedCrossRef de Kerchove L, Vanoverschelde JL, Poncelet A, Glineur D, Rubay J, Zech F, Noirhomme P, El Khoury G (2007) Reconstructive surgery in active mitral valve endocarditis: feasibility, safety and durability. Eur J Cardiothorac Surg 31:592–599PubMedCrossRef
17.
Zurück zum Zitat Zegdi R, Debieche M, Latremouille C, Lebied D, Chardigny C, Grinda JM, Chauvaud S, Deloche A, Carpentier A, Fabiani JN (2005) Long-term results of mitral valve repair in active endocarditis. Circulation 111:2532–2536PubMedCrossRef Zegdi R, Debieche M, Latremouille C, Lebied D, Chardigny C, Grinda JM, Chauvaud S, Deloche A, Carpentier A, Fabiani JN (2005) Long-term results of mitral valve repair in active endocarditis. Circulation 111:2532–2536PubMedCrossRef
18.
Zurück zum Zitat Gammie JS, O’Brien SM, Griffith BP, Peterson ED (2005) Surgical treatment of mitral valve endocarditis in North America. Ann Thorac Surg 80:2199–2204PubMedCrossRef Gammie JS, O’Brien SM, Griffith BP, Peterson ED (2005) Surgical treatment of mitral valve endocarditis in North America. Ann Thorac Surg 80:2199–2204PubMedCrossRef
19.
Zurück zum Zitat Iung B, Rousseau-Paziaud J, Cormier B, Garbarz E, Fondard O, Brochet E, Acar C, Couetil JP, Hvass U, Vahanian A (2004) Contemporary results of mitral valve repair for infective endocarditis. J Am Coll Cardiol 43:386–392PubMedCrossRef Iung B, Rousseau-Paziaud J, Cormier B, Garbarz E, Fondard O, Brochet E, Acar C, Couetil JP, Hvass U, Vahanian A (2004) Contemporary results of mitral valve repair for infective endocarditis. J Am Coll Cardiol 43:386–392PubMedCrossRef
20.
Zurück zum Zitat Podesser BK, Rodler S, Hahn R, Eigenbauer E, Vodrazka M, Moritz A, Laufer G, Simon P, Wolner E (2000) Mid-term follow up of mitral valve reconstruction due to active infective endocarditis. J Heart Valve Dis 9:335–340PubMed Podesser BK, Rodler S, Hahn R, Eigenbauer E, Vodrazka M, Moritz A, Laufer G, Simon P, Wolner E (2000) Mid-term follow up of mitral valve reconstruction due to active infective endocarditis. J Heart Valve Dis 9:335–340PubMed
21.
Zurück zum Zitat Musci M, Hubler M, Pasic M, Amiri A, Stein J, Siniawski H, Weng Y, Hetzer R (2010) Surgery for active infective mitral valve endocarditis: a 20-year, single-center experience. J Heart Valve Dis 19:206–214 discussion 15PubMed Musci M, Hubler M, Pasic M, Amiri A, Stein J, Siniawski H, Weng Y, Hetzer R (2010) Surgery for active infective mitral valve endocarditis: a 20-year, single-center experience. J Heart Valve Dis 19:206–214 discussion 15PubMed
22.
Zurück zum Zitat Musci M, Weng Y, Hubler M, Chavez T, Qedra N, Kosky S, Stein J, Siniawski H, Hetzer R (2009) Predictors of early mortality in patients with active infective native or prosthetic aortic root endocarditis undergoing homograft aortic root replacement. Clin Res Cardiol 98:443–450PubMedCrossRef Musci M, Weng Y, Hubler M, Chavez T, Qedra N, Kosky S, Stein J, Siniawski H, Hetzer R (2009) Predictors of early mortality in patients with active infective native or prosthetic aortic root endocarditis undergoing homograft aortic root replacement. Clin Res Cardiol 98:443–450PubMedCrossRef
23.
Zurück zum Zitat Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S, Casalta JP, Danchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainardi JL, Ruimy R, Vandenesch F (2002) Changing profile of infective endocarditis: results of a 1-year survey in France. Jama 288:75–81PubMedCrossRef Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S, Casalta JP, Danchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainardi JL, Ruimy R, Vandenesch F (2002) Changing profile of infective endocarditis: results of a 1-year survey in France. Jama 288:75–81PubMedCrossRef
24.
Zurück zum Zitat Hecht SR, Berger M (1992) Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes. Ann Intern Med 117:560–566PubMed Hecht SR, Berger M (1992) Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes. Ann Intern Med 117:560–566PubMed
25.
Zurück zum Zitat Kang CH, Ahn H, Kim KH, Kim KB (2005) Long-term result of 1144 CarboMedics mechanical valve implantations. Ann Thorac Surg 79:1939–1944PubMedCrossRef Kang CH, Ahn H, Kim KH, Kim KB (2005) Long-term result of 1144 CarboMedics mechanical valve implantations. Ann Thorac Surg 79:1939–1944PubMedCrossRef
26.
Zurück zum Zitat Couetil JP, Argyriadis PG, Shafy A, Cohen A, Berrebi AJ, Loulmet DF, Chachques JC, Carpentier AF (2002) Partial replacement of the tricuspid valve by mitral homografts in acute endocarditis. Ann Thorac Surg 73:1808–1812PubMedCrossRef Couetil JP, Argyriadis PG, Shafy A, Cohen A, Berrebi AJ, Loulmet DF, Chachques JC, Carpentier AF (2002) Partial replacement of the tricuspid valve by mitral homografts in acute endocarditis. Ann Thorac Surg 73:1808–1812PubMedCrossRef
27.
Zurück zum Zitat Kay JH, Maselli-Campagna G, Tsuji KK (1965) Surgical treatment of tricuspid insufficiency. Ann Surg 162:53–58PubMedCrossRef Kay JH, Maselli-Campagna G, Tsuji KK (1965) Surgical treatment of tricuspid insufficiency. Ann Surg 162:53–58PubMedCrossRef
Metadaten
Titel
Repair for active infective atrioventricular valve endocarditis: 23-year single center experience
verfasst von
Michele Musci
Michael Hübler
Aref Amiri
Julia Stein
Susanne Kosky
Yuguo Weng
Miralem Pasic
Roland Hetzer
Publikationsdatum
01.11.2011
Verlag
Springer-Verlag
Erschienen in
Clinical Research in Cardiology / Ausgabe 11/2011
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-011-0331-2

Weitere Artikel der Ausgabe 11/2011

Clinical Research in Cardiology 11/2011 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.